Also categorized in BoardMoves:
Twitter's Jack Dorsey To Join Disney Board Of Directors
x hide permanently

Rubius Therapeutics Appoints Natalie Holles to its Board of Directors

World News Media Monitoring

CAMBRIDGE, Mass., March 25, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new class of cellular medicines, today announced the appointment of Natalie Holles, president and chief operating officer of Audentes Therapeutics, as a member of the company’s board of directors...

Mentions: Nasdaq Natalie Holles Rubius Therapeutics